API Gallery
The Hydroxocobalamin market is projected to grow at a CAGR of 6.1% from 2025 to 2035, driven by increasing awareness of vitamin B12 deficiency, expanding use in cyanide poisoning treatment, and its adoption in nutritional therapies.
The Hydroxyprogesterone Caproate market is projected to grow at a CAGR of 5.7% from 2025 to 2035, driven by its use in the prevention of preterm birth, management of high-risk pregnancies, and treatment of specific gynecological and hormonal disorders.
The Hydroxychloroquine Sulphate market is projected to grow at a CAGR of 4.8% from 2025 to 2035, supported by its established role in the treatment of autoimmune diseases, including rheumatoid arthritis, lupus erythematosus, and malaria prophylaxis.
The Hydroxyurea market is projected to grow at a CAGR of 5.5% from 2025 to 2035, driven by its established use in the treatment of various cancers and sickle cell disease, along with ongoing research into its broader therapeutic applications.
The Hydroxyurea market is projected to grow at a CAGR of 5.5% from 2025 to 2035, driven by its established use in the treatment of various cancers and sickle cell disease, along with ongoing research into its broader therapeutic applications.
The Hydroxyzine HCl market is projected to grow at a CAGR of 5.1% from 2025 to 2035, driven by its continued use in the treatment of anxiety, allergies, nausea, and as a sedative in various medical applications.
The Hymecromone market is projected to grow at a CAGR of 4.6% from 2025 to 2035, driven by its expanding use in liver diseases, digestive health, and as an adjunctive treatment for various conditions related to the liver and biliary tract.
The Atazanavir Sulfate market is witnessing a CAGR of 5.4% during the forecast period of 2025-2035. Atazanavir sulfate is a critical antiretroviral medication employed in the treatment of Human Immunodeficiency Virus (HIV) infection.
The Beclomethasone Dipropionate market is witnessing a CAGR of 5.4% during the forecast period of 2025-2035.
The Bedaquiline market is witnessing a CAGR of 6% during the forecast period of 2025-2035. Bedaquiline represents a significant advancement in the treatment of multidrug-resistant tuberculosis (MDR-TB).
The Belinostat market is witnessing a CAGR of 7% during the forecast period of 2025-2035. Belinostat, sold under the brand name Beleodaq, is a histone deacetylase inhibitor (HDAC) that is formulated for the management of hematological malignancies and solid tumors.
The Belladonna Alkaloids market is witnessing a CAGR of 7% during the forecast period of 2025-2035. Belladonna alkaloids, which are obtained from the Atropa belladonna, include atropine, hyoscyamine, and scopolamine.
The Belladonna Leaf Extract market is witnessing a CAGR of 7% during the forecast period of 2025-2035 Belladonna, or Atropa belladonna, is a perennial herb indigenous to Europe, North Africa, and Western Asia.
The Belotecan market is witnessing a CAGR of 7% during the forecast period of 2025-2035. Belotecan is a semi-synthetic camptothecin derivative, and it belongs to the class of topoisomerase I inhibitors.
The Belumosudil market is witnessing a CAGR of 5.6% during the forecast period of 2025-2035.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
